Increase of Bax and p16INK4A expression was also seen in sporadic invasive carcinomas (Bax, four out of six examined cases; p16INK4A, four out of six examined cases), although the two did not well match each other. The gene discussed is CDKN2A; the disease is invasive carcinoma.